Extracorporeal Membrane Oxygenation System Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-05　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 395 Mn
2033 年預估規模: USD 571 Mn
年複合成長率 CAGR: 5.4%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Extracorporeal Membrane Oxygenation System Market, By Modality (Arteriovenous, Venoarteial, and Venovenous), By Application (Extracorporeal cardiopulmonary resuscitation, Cardiac, and Respiratory), By Age Group (Neonatal, Pediatric, and Adults), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen. Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect. Market Dynamics Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Key features of the study • This report provides in-depth analysis of the global extracorporeal membrane oxygenation system market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global extracorporeal membrane oxygenation system market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market Market Segmentation • By Modality Insights (Revenue, USD Mn, 2021 - 2033) o Arteriovenous o Venoarteial o Venovenous • By Application Insights (Revenue, USD Mn, 2021 - 2033) o Extracorporeal cardiopulmonary resuscitation o Cardiac o Respiratory • By Age Group Insights (Revenue, USD Mn, 2021 - 2033) o Neonatal o Pediatric o Adults • By Region Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players o Medtronic o Getinge AB o LivaNova PLC o Terumo Corporation o XENIOS AG o OriGen Biomedical o EUROSETS o NIPRO o MicroPort Scientific Corporation

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Modality  Market Snapshot, By Application  Market Snapshot, By Age Group  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Technological Advancements o PEST Analysis o PORTER’S Five Forces 4. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Arteriovenous  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Venoarteial  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Venovenous  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 5. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Extracorporeal cardiopulmonary resuscitation  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Cardiac  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Respiratory  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 6. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Neonatal  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Pediatric  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Adults  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 7. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o UK o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Medtronic  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Getinge AB  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o LivaNova PLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Terumo Corporation  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o XENIOS AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o OriGen Biomedical  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o EUROSETS  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o NIPRO  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o MicroPort Scientific Corporation  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

MedtronicGetinge ABLivaNova PLCTerumo CorporationXENIOS AGOriGen BiomedicalEUROSETSNIPROMicroPort Scientific Corporation

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們